- Home >
- Clinicals Trials >
- BFR ESS 01
Back to clinical trials listSarcomas
BFR ESS 01
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
- Open at Paris since : 11/07/2019
- Target : Adult
- Phase : Phase II
Trial description
The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).
Url of the trialMain investigator
